Persistence of Oral DNA Adducts in Smokers and Vapers
NCT06983392 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2026-02-13
Summary
This study aims to better understand what damage caused to oral cells from smoking and vaping might be important in the formation of oral cancers. We will compare levels of DNA damage between those asked to stop smoking or vaping to those who continue to smoke or vape and those who never use tobacco or nicotine products. The goal is to identify damage that is found at higher levels or remains in the oral cells longer because they might be more important in causing cancer than other types of damage.
Conditions
- Smokers
- Vaping
- Healthy Volunteers
Interventions
- BEHAVIORAL
-
Abstain from smoking/vaping
They may be asked to stop smoking cigarettes or vaping during the study for 21 days. If they are asked to abstain from their product use they will be given nicotine patches and/or lozenges to help with abstinence during the study.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Stephen Hecht · University of Minnesota
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-03-01
- Primary Completion
- 2029-07-30
- Completion
- 2030-07-30
More Related Trials
-
Effects of Novel E-cigarette Constituents on Adults TCORS 3.0
NCT05932745 ·Status: RECRUITING ·Phase: NA
-
Abuse Liability and Appeal of Oral Nicotine Products
NCT06506162 ·Status: RECRUITING ·Phase: NA
-
Metabolism of Deuterated NNN in Smokeless Tobacco Users
NCT02414477 ·Status: TERMINATED ·Phase: PHASE1
-
The Effect of Tobacco Products on Wound Healing
NCT04870970 ·Status: ACTIVE_NOT_RECRUITING
-
Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine
NCT00777569 ·Status: COMPLETED ·Phase: PHASE2
-
Manipulating Tobacco Constituents in Female Menthol Smokers
NCT02048852 ·Status: COMPLETED ·Phase: NA
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
NCT00939029 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Impact of Chronic E-Cigarette Usage on Microvascular Health
NCT06860698 ·Status: RECRUITING
-
Perceptions of Vaping Products
NCT06868368 ·Status: COMPLETED ·Phase: NA
-
Vaped Phenanthrene
NCT07134426 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of an Oral Nicotine Product in Smokeless Tobacco Users
NCT05280769 ·Status: COMPLETED ·Phase: NA
-
Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure
NCT03998735 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effect of Different E-cigarette Cooling Flavors on Adults' Sensory Experience TCORS 3.0
NCT05932693 ·Status: COMPLETED ·Phase: NA
-
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
NCT03272685 ·Status: COMPLETED ·Phase: PHASE3
-
CSD231005 Nicotine Pouch Biomarkers of Exposure
NCT06303115 ·Status: COMPLETED ·Phase: NA
-
Varenicline For Smokers In Recovery From Alcohol Dependence
NCT01092702 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluating New Nicotine Standards for Cigarettes - Project 3
NCT03194256 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes
NCT03559725 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Changes in Smokers Using An Oral Tobacco-Derived Nicotine Product
NCT04079933 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
NCT04231539 ·Status: COMPLETED ·Phase: NA
-
Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS
NCT04107779 ·Status: COMPLETED ·Phase: NA
-
Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction
NCT01018394 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.
NCT01227720 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days
NCT01234142 ·Status: COMPLETED ·Phase: PHASE1